5-MEMBERED NITROGEN CONTAINING HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
申请人:Shimizu Kazuo
公开号:US20120289506A1
公开(公告)日:2012-11-15
5-membered heterocyclic derivatives represented by general formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, or salts thereof. In the formula (I), T represents nitro, cyano and the like; ring J represents aryl or heteroaryl; Q represents carboxy, 5-tetazolyl and the like; Y represents H, OH, NH
2
, halogen, haloalkyl and the like; X
1
and X
2
independently represent CR
2
or N; R
2
represents H, alkyl and the like; R
1
represents halogen, cyano, haloalkyl, A-D-E-G-L-M, —N(-D-L-M)
2
and the like, A represents a single bond, O, S and the like; D, G and M independently represent optionally substituted alkylene, cycloalkylene, heterocycloalkylene, arylene, heteroarylene and the like; E and L independently represent a single bond, O, S, COO, SO
2
and the like.
通式(I)所表示的5元杂环衍
生物具有
黄嘌呤氧化酶抑制活性,并且可作为预防或治疗与血清
尿酸水平异常相关的疾病的药剂,其前药或盐。在公式(I)中,T表示硝基,
氰基等;环J表示芳基或杂芳基;Q表示羧基,5-
四唑基等;Y表示H,OH,NH2,卤素,卤代烷基等;X1和X2独立地表示CR2或N;R2表示H,烷基等;R1表示卤素,
氰基,卤代烷基,A-D-E-G-L-M,-N(-D-L-M)2等,其中A表示单键,O,S等;D,G和M分别表示可选取代的烷基,环烷基,杂环烷基,芳基,杂芳基等;E和L独立地表示单键,O,S,COO,SO2等。